Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE

NCT03275922 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Placebo ZNS
DRUG: ZNS

Sponsor

Impax Laboratories, LLC

Collaborators

[object Object]